FT Vest SandP 500 Dividend Aristocrats Target Income ETF (KNG)
Live price chart, market sentiment, and community perspectives for FT Vest SandP 500 Dividend Aristocrats Target Income ETF (CBOE: KNG).
Live price chart, market sentiment, and community perspectives for FT Vest SandP 500 Dividend Aristocrats Target Income ETF (CBOE: KNG).
On our desk, market sentiment for KNG is leaning toward a cautious hold. While the fund provides a robust monthly yield of roughly 8.1% to 8.6% driven by its covered call overlay on 69 dividend aristocrats, the heavy reliance on return of capital for distributions and a higher expense ratio of 0.74% create persistent headwinds compared to non-option benchmarks like NOBL.
Reviewing the quantitative metrics, KNG has lagged behind the ProShares SandP 500 Dividend Aristocrats ETF since inception, yielding a total return of 93% over eight years versus 107% for NOBL. The total net assets stand near $3.41 billion, but the systematic overwriting of the entire portfolio caps capital appreciation upside during secular market turnarounds.
When evaluating KNG's strategy for income-focused accounts, note that the index is managed by SandP Opco with Vest Financial serving as the sub-advisor. The fund normally invests at least 80% of its total assets in the common stocks and call options that comprise the index, strictly following a target income structure designed to outperform the SandP 500's yield profile.
Short interest tracking on BATS:KNG shows a 50.1% increase in late July 2026, reaching 214,304 shares shorted. With average daily volume around 300,000 shares, the short interest ratio remains very low at approximately 0.7 days, indicating minimal bearish positioning despite broader analyst consensus noting lagging risk-adjusted returns relative to competing selective buy-write ETFs.
From a sector allocation perspective, KNG overweights consumer staples and industrials while maintaining an acute underweight in technology, consumer discretionary, and communication services. This defensive stance limits its technology exposure, leaving the ETF vulnerable to underperformance during tech-driven bull markets like the current AI era.
Explore plasma cleansing, somatic organ swaps, and BCI.